Vice President Mike Pence predicted that around 200 million Americans will be killed by drug overdoses by the time his presidency is over. Pence famously signed the Pharmaceutical Research and Manufacturers of America’s Prescription Drug User Fee Act into law in September of 2015, essentially improving enforcement of the rules that regulate bulk pharmaceutical purchases and rebates.
The Prescription Drug User Fee Act allows pharmacies to receive rebates and a 2.3 percent fee from the pharmaceutical industry for some prescriptions they fill. To boost enforcement of the changes, the federal government created a website, dpa.gov, that provides “a repository of records and information about pharmaceuticals that seniors care for and caregivers are most likely to access.” Prescription drug addicts report spending over a quarter million dollars on drugs every year.
Despite big profits for drug companies, the bills is poorly administered as it affects only about one-quarter of prescription drugs. Democrats have called for lowering the pharmaceutical industry’s total opioid excise tax to eliminate the incentive to evade taxes, arguing it puts the government on the hook for the cost of the crimes occurring.
Vice President Pence said in the segment that the government needs a solution to addicts and overdoses without giving up funding for opioid drugs, as the Inquisitr previously reported.“There’s 200 million Americans in the years ahead will be dying from this combination of drugs that exist and will keep on dying,” the vice president said. “But in return for doing nothing, we’re guaranteeing 100,000 people a year in the President’s budget, the tip of the opioid iceberg, 200 million Americans in the years ahead will be dying from this combination of drugs that exist and will keep on dying.”
Despite being a presidential candidate who promised to end the opioid epidemic, some drug company CEOs are already offering solutions to end the country’s addiction problem. The CEO of leading drugmaker Pfizer, Ian Read, made a viral video, claiming that drug companies are the top drugmaker in the U.S. Period.